Reuters logo
BRIEF-Regeneron Pharma shares resume trading, up 16 percent
May 1, 2013 / 3:21 PM / 5 years ago

BRIEF-Regeneron Pharma shares resume trading, up 16 percent

NEW YORK, May 1 (Reuters) - Regeneron Pharmaceuticals Inc : * Shares resume trading, up 16 percent * Shares as shares of Allergan slide after co says vision drug approval

likely delayed * Shares up 13.2 percent as shares of Allergan slide after co says

vision drug approval likely delayed

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below